All In Biotech

Drug Trial Radar · NCT01489228

Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease

Phase 2 Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Three Oral E1224 Dosing Regimens and Benznidazole for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease

Last checked: Nov 20, 2026Latest source record: Dec 21, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 230 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

230

Planned (sponsor's estimate)

Start

Jun 2011

Primary completion

Aug 2012

Study completion Dec 2013

Sponsor

Lead sponsor
Drugs for Neglected DiseasesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Eisai Co., Ltd.
First posted
Dec 9, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the safety and efficacy of E1224, a pro-drug of ravuconazole, in individuals with chronic indeterminate Chagas disease recruited in research centres in Tarija and Cochabamba, Bolivia.

Conditions

  • Chronic Chagas Disease, Indeterminate

Interventions

  • E1224Drug

    100 mg tablets

  • BenznidazoleDrug

    100mg tablets

  • PlaceboDrug

    tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serial negative qualitative Polymerase Chain Reaction (PCR) results (3 negative PCR results from 3 samples to be collected over 7 days) as a measure of parasitological cure at end of treatmentTime frame: Day 65 (end of treatment)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Plataforma de Atención Integral a los Pacientes con Enfermidad de Chagas

    Cochabamba, Cochabamba, Bolivia · Recruiting

  • Plataforma de Atención Integral a los Pacientes con Enfermidad de Chagas

    Tarija, Tarija Department, Bolivia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.